O75874 |
IDHC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 |
IDHC_HUMAN |
Liver cancer [ICD-11: 2C12] |
O75874 |
IDHC_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
O75874 |
IDHC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O75874 |
IDHC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 |
IDHC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O95398 |
RPGF3_HUMAN |
Epidermal dysplasias [ICD-11: EK90] |
P43220 |
GLP1R_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P43220 |
GLP1R_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P43220 |
GLP1R_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P43220 |
GLP1R_HUMAN |
Type-1/2 diabete [ICD-11: 5A10-5A11] |
P43220 |
GLP1R_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P43220 |
GLP1R_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P43220 |
GLP1R_HUMAN |
Dyspepsia [ICD-11: MD92] |
P43220 |
GLP1R_HUMAN |
Irritable bowel syndrome [ICD-11: DD91] |
P43220 |
GLP1R_HUMAN |
Intracranial injury [ICD-11: NA07] |
P43220 |
GLP1R_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
P53350 |
PLK1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P53350 |
PLK1_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P53350 |
PLK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P53350 |
PLK1_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P53350 |
PLK1_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P53350 |
PLK1_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P53350 |
PLK1_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P53350 |
PLK1_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P53350 |
PLK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P84022 |
SMAD3_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
P84022 |
SMAD3_HUMAN |
Kidney fibrosis [ICD-11: GC01] |
Q16236 |
NF2L2_HUMAN |
Ataxic disorder [ICD-11: 8A03] |
Q16236 |
NF2L2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q16236 |
NF2L2_HUMAN |
Glaucoma [ICD-11: 9C61] |
Q16236 |
NF2L2_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q16236 |
NF2L2_HUMAN |
Macular degeneration [ICD-11: 9B75] |
Q16236 |
NF2L2_HUMAN |
Melanoma [ICD-11: 2C30] |
Q16236 |
NF2L2_HUMAN |
Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
Q16236 |
NF2L2_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
Q16236 |
NF2L2_HUMAN |
Subarachnoid haemorrhage [ICD-11: 8B01] |
Q16236 |
NF2L2_HUMAN |
Urinary system clinical sympton [ICD-11: MF8Y] |
Q16236 |
NF2L2_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 |
NF2L2_HUMAN |
Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
Q16236 |
NF2L2_HUMAN |
Motor neuron disease [ICD-11: 8B60] |
Q16236 |
NF2L2_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
O75604 |
UBP2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |